Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Basic principles for utilizing combination differentiation agents.

S Waxman, W Scher, B M Scher

    Cancer Detection and Prevention
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cancer mortality in the elderly in 11 countries worldwide, 1970-2015.

    Annals of oncology : official journal of the European Society for Medical Oncology·2019
    Same author

    Emerging Roles of Epigenetic Regulator Sin3 in Cancer.

    Advances in cancer research·2016
    Same author

    Downregulation of Mcl-1 through GSK-3β activation contributes to arsenic trioxide-induced apoptosis in acute myeloid leukemia cells.

    Leukemia·2012
    Same author

    Fludarabine phosphate selectively inhibits growth and modifies the antigenic phenotype of human glioblastoma-multiforme cells expressing a multidrug resistance phenotype.

    International journal of oncology·2011
    Same author

    Induction of erythroid differentiation is associated with inhibition of glycolysis and a decrease in fructose 2,6-bisphosphate levels.

    International journal of oncology·2011
    Same author

    The 12th international conference on differentiation therapy: targeting the aberrant growth, differentiation and cell death programs of cancer cells.

    Cell death and differentiation·2011
    Same journal

    Melanoma metastasis to the breast: a diagnostic pitfall.

    Cancer detection and prevention·2009
    Same journal

    Development of a rat model by 3,4-benzopyrene intra-pulmonary injection and evaluation of the effect of green tea drinking on p53 and bcl-2 expression in lung carcinoma.

    Cancer detection and prevention·2009
    Same journal

    Combined effect of NAT2, MTR and MTHFR genotypes and tobacco on bladder cancer susceptibility in Tunisian population.

    Cancer detection and prevention·2009
    Same journal

    Vitamin D receptor gene polymorphism(s) and breast cancer risk in north Indians.

    Cancer detection and prevention·2009
    Same journal

    Epidemiology of primary brain tumors in the Middle Eastern population in California, USA 2001-2005.

    Cancer detection and prevention·2009
    Same journal

    Lifetime consumption of alcoholic beverages and risk of 13 types of cancer in men: results from a case-control study in Montreal.

    Cancer detection and prevention·2009
    See all related articles

    This study explores cancer treatment via tumor cell differentiation induction. Researchers identified agents that trigger differentiation, potentially leading to tumor cell death, distinct from traditional cytotoxic therapies.

    Area of Science:

    • Oncology
    • Cell Biology
    • Cancer Therapeutics

    Background:

    • Tumor cell differentiation induction is a novel cancer treatment strategy.
    • Numerous agents (~300) induce differentiation in mouse erythroleukemia (MEL) cells, but mechanisms require elucidation.
    • Differentiation therapy design necessitates tumor-specific approaches, optimized timing, and potential synergistic inducer combinations.

    Purpose of the Study:

    • To investigate the potential of differentiation induction as a cancer treatment modality.
    • To differentiate between specific tumor cell destruction via differentiation and non-specific cytotoxic effects.
    • To identify parameters for assessing commitment to terminal cell division (TCD) following differentiation induction.

    Main Methods:

    • In vitro studies using the mouse erythroleukemia (MEL) cell system.

    Related Experiment Videos

  • Screening of approximately 300 agents for differentiation-inducing capabilities.
  • Evaluation of biological and biochemical markers, including DNA ligase activity, to distinguish differentiation-induced TCD from non-specific cytotoxicity.

    • Main Results:

    • Over 300 agents identified that can induce differentiation in tumor cell lines.
    • Differentiation induction can lead to terminal cell division (TCD) or programmed cell death.
    • A selective decrease in DNA ligase activity in MEL cells may serve as a marker for commitment to TCD, differentiating it from cytotoxic effects.

    Conclusions:

    • Differentiation therapy offers a targeted approach to cancer treatment by inducing tumor cell death.
    • Distinguishing differentiation-induced TCD from non-specific cytotoxicity is crucial for effective therapy design.
    • Biological and biochemical markers, like DNA ligase activity, are essential for developing in vivo differentiation-inducing agents.